Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
25 and 50 mg diclofenac K film coated immediate release tablets More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
25mg dosage strenght for the OTC market in film coated tablets More
Adhesive Patch of 90 sq. cm. and containing as active ingredient 100 mg. of ketoprofen for the local treatment of traumatic injuries and extra-articular rheumatism More
Collagen-based biodegradable matrices for localized drug delivery More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Transdermal pain patch for the treatment of moderate to severe chronic pain. More
The First Line of Therapy in Severe Migraine Attacks More
12,5 mg diclofenac K film coated immediate release tablets (OTC) More
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Related Reports
Market Research Reports provided by reports.innovaro.com
Apr 2010 - 22 pages - $99
Jun 2006 - 1068 pages - $2,495
Sep 2011 - 97 pages - $3,500
Oct 2010 - 53 pages - $1,000
Jan 2010 - $75
Jun 2010 - 22 pages - $125
Feb 2011 - 75 pages - $1,000
Jul 2011 - 74 pages - $3,800
Aug 2010 - $15,200
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Anesthesia
- Neuralgia
- Pain management general
- Pain, acute
- Pain, AIDS-related
- Pain, back upper/lower
- Pain, cancer
- Pain, chronic
- Pain, inflammatory
- Pain, neuropathic
- Pain, post-operative
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us